Oxidative stress and antioxidant therapy in Parkinson's disease
- 1 January 1996
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 48 (1) , 1-19
- https://doi.org/10.1016/0301-0082(95)00029-1
Abstract
No abstract availableKeywords
This publication has 182 references indexed in Scilit:
- Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidasePublished by Elsevier ,2004
- Neural transplantation, trophic factors and Parkinson's diseaseLife Sciences, 1994
- Glutamatergic drugs in Parkinson's diseaseLife Sciences, 1994
- Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's deseaseLife Sciences, 1994
- Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brainJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Monoamine oxidase-B inhibition: a comparison of in vivo and ex vivo measures of reversible effectsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1988
- Glutathione peroxidase activity in Parkinson's disease brainNeuroscience Letters, 1985
- Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: Diagnosis and treatment with alpha tocopherolThe Journal of Pediatrics, 1982
- Multiple forms of monoamine oxidase: Fact and artefactLife Sciences, 1976
- The potentiation of the anti akinetic effect after L-Dopa treatment by an inhibitor of Mao-B, deprenilJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1975